SCHEMBL18845877

SCHEMBL18845877

CC1(C)c2ccccc2-c2c1ccc1c(-c3ccc(-c4ccc(-c5cc(-c6ccc(-c7ccccc7)cc6)nc(-c6ccccc6)n5)cc4)cc3)nc3ccccc3c21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 9/20 0.38
KMT2A Q03164 9/20 0.38
ATM Q13315 1/20 0.38
ALDH1A1 P00352 6/20 0.36
MAPT P10636 6/20 0.36
HPGD P15428 6/20 0.36
NTSR1 P30989 1/20 0.36
ACACA Q13085 2/20 0.36
DHODH Q02127 3/20 0.34
KDM4E B2RXH2 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
LMNA P02545 2/20 0.33
WHR1 P49842 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
CYP2C19 P33261 1/20 0.33
GLA P06280 1/20 0.33
ACHE P22303 1/20 0.33
CYP1A1 P04798 1/20 0.32
CYP1A2 P05177 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18845712 1.00 MEN1 (0.38) MEN1KMT2AATMALDH1A1MAPT
SCHEMBL18845930 1.00 MEN1 (0.38) MEN1KMT2AATMALDH1A1MAPT
SCHEMBL18845735 0.99 MEN1 (0.38) MEN1KMT2AATMALDH1A1MAPT
SCHEMBL18845806 0.99 MEN1 (0.38) MEN1KMT2AATMALDH1A1MAPT
SCHEMBL18846054 0.95 MEN1 (0.36) MEN1KMT2AATMALDH1A1MAPT
SCHEMBL18845941 0.93 MEN1 (0.34) MEN1KMT2AATMALDH1A1MAPT
SCHEMBL18845710 0.92 ATM (0.44) MEN1KMT2AATMALDH1A1MAPT
SCHEMBL18846057 0.92 MEN1 (0.34) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL18845731 0.92 ATM (0.47) MEN1KMT2AATMALDH1A1MAPT
SCHEMBL18845880 0.92 TSHR (0.39) MEN1KMT2AATMALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10446765-B2 Heterocyclic compound and organic light emitting element using same HEESUNG MATERIAL LTD. (KR) 2019-10-15 US disclosed
US-20170133602-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-11 US disclosed
US-20170133602-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170133602-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME CRY1, CRY2, PER2 MEN1 1034/4885KMT2A 579/4885ATM 3417/4885
US-10446765-B2 Heterocyclic compound and organic light emitting element using same CRY1, CRY2, PER2 MEN1 1034/4885KMT2A 579/4885ATM 3417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.